Severe obesity in children and adolescents: Identification, associated health risks, and treatment approaches: A scientific statement from the American Heart Association

Circulation

Volumn 128, Issue 15, 2013, Pages 1689-1712

  Kelly, Aaron S ^a   Barlow, Sarah E ^a   Rao, Goutham ^a   Inge, Thomas H ^a   Hayman, Laura L ^a   Steinberger, Julia ^a   Urbina, Elaine M ^a   Ewing, Linda J ^a   Daniels, Stephen R ^a  

^a NONE

Author keywords

Adolescents; AHA Scientific Statements; Children; Obesity; Risk factors

Indexed keywords

AMFEBUTAMONE; EXENDIN 4; LORCASERIN; METFORMIN; NALTREXONE; PHENTERMINE; PHENTERMINE PLUS TOPIRAMATE; SIBUTRAMINE; TETRAHYDROLIPSTATIN; TOPIRAMATE;

ABDOMINAL PAIN; ADENOTONSILLECTOMY; ADOLESCENT DISEASE; AGE DISTRIBUTION; ANASTOMOSIS LEAKAGE; AORTA ATHEROSCLEROSIS; ARTICLE; BEHAVIOR MODIFICATION; BILIOPANCREATIC BYPASS; CARDIOMETABOLIC RISK; CARDIOVASCULAR RISK; CAROTID ATHEROSCLEROSIS; CHILDHOOD OBESITY; CORONARY ARTERY ATHEROSCLEROSIS; DAYTIME SOMNOLENCE; DIASTOLIC BLOOD PRESSURE; DIASTOLIC DYSFUNCTION; DRUG INDUCED DISEASE; DYSLIPIDEMIA; ETHNIC DIFFERENCE; EVENING DOSAGE; GASTRIC BANDING; HEALTH HAZARD; HEALTH INSURANCE; HEART ATRIUM ENLARGEMENT; HUMAN; HYPERCAPNIA; HYPERINSULINEMIA; HYPERTENSION; HYPOXEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; INTESTINE OBSTRUCTION; INTESTINE RESECTION; LIFESTYLE MODIFICATION; MEASUREMENT ERROR; MEDICAL SOCIETY; METABOLIC SYNDROME X; MORNING DOSAGE; NAUSEA AND VOMITING; NONALCOHOLIC FATTY LIVER; PEDIATRIC SURGERY; PNEUMONIA; POSTOPERATIVE HEMORRHAGE; POVERTY; PREVALENCE; PRIORITY JOURNAL; PSYCHOSOCIAL DISORDER; QUALITY OF LIFE; RACE DIFFERENCE; RANDOMIZED CONTROLLED TRIAL (TOPIC); ROUX Y ANASTOMOSIS; SEX DIFFERENCE; SIDE EFFECT; SLEEP DISORDERED BREATHING; SLEEVE GASTRECTOMY; SOCIAL PSYCHOLOGY; STOMACH BYPASS; ULCER; VENOUS THROMBOEMBOLISM; VITAMIN DEFICIENCY; WAIST CIRCUMFERENCE; WOUND INFECTION;

ADOLESCENTS; AHA SCIENTIFIC STATEMENTS; CHILDREN; OBESITY; RISK FACTORS;

ADOLESCENT; AMERICAN HEART ASSOCIATION; CHILD; HUMANS; OBESITY, MORBID; RISK FACTORS; UNITED STATES;

EID: 84885843346     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIR.0b013e3182a5cfb3     Document Type: Article

References (269)

1. Ogden CL, Carroll MD, Curtin LR, Lamb MM, Flegal KM. Prevalence of high body mass index in US children and adolescents, 2007-2008. JAMA. 2010;303:242-249
2. Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of obesity and trends in body mass index among US children and adolescents, 1999-2010. JAMA. 2012;307:483-490
3. Skelton JA, Cook SR, Auinger P, Klein JD, Barlow SE. Prevalence and trends of severe obesity among US children and adolescents. Acad Pediatr. 2009;9:322-329
4. Wang YC, Gortmaker SL, Taveras EM. Trends and racial/ethnic disparities in severe obesity among US children and adolescents, 1976-2006. Int J Pediatr Obes 2011;6:12-20
5. Flegal KM, Wei R, Ogden CL, Freedman DS, Johnson CL, Curtin LR. Characterizing extreme values of body mass index-for-age by using the 2000 Centers for Disease Control and Prevention growth charts. Am J Clin Nutr. 2009;90:1314-1320
6. Freedman DS, Mei Z, Srinivasan SR, Berenson GS, Dietz WH. Cardiovascular risk factors and excess adiposity among overweight children and adolescents: The Bogalusa Heart Study. J Pediatr. 2007;150:12-17.e2
7. Koebnick C, Smith N, Coleman KJ, Getahun D, Reynolds K, Quinn VP, Porter AH, Der-Sarkissian JK, Jacobsen SJ. Prevalence of extreme obesity in a multiethnic cohort of children and adolescents. J Pediatr. 2010;157:26-31.e2
8. Calcaterra V, Klersy C, Muratori T, Telli S, Caramagna C, Scaglia F, Cisternino M, Larizza D. Prevalence of metabolic syndrome (MS) in children and adolescents with varying degrees of obesity. Clin Endocrinol (Oxf). 2008;68:868-872
9. Gidding SS, Nehgme R, Heise C, Muscar C, Linton A, Hassink S. Severe obesity associated with cardiovascular deconditioning, high prevalence of cardiovascular risk factors, diabetes mellitus/hyperinsulinemia, and respiratory compromise. J Pediatr. 2004;144:766-769
10. Ice CL, Murphy E, Cottrell L, Neal WA. Morbidly obese diagnosis as an indicator of cardiovascular disease risk in children: Results from the CARDIAC Project. Int J Pediatr Obes. 2011;6:113-119
11. Kapiotis S, Holzer G, Schaller G, Haumer M, Widhalm H, Weghuber D, Jilma B, Röggla G, Wolzt M, Widhalm K, Wagner OF. A proinflammatory state is detectable in obese children and is accompanied by functional and morphological vascular changes. Arterioscler Thromb Vasc Biol. 2006;26:2541-2546
12. Kelly AS, Hebbel RP, Solovey AN, Schwarzenberg SJ, Metzig AM, Moran A, Sinaiko AR, Jacobs DR Jr, Steinberger J. Circulating activated endothelial cells in pediatric obesity. J Pediatr. 2010;157:547-551
13. Kelly AS, Metzig AM, Schwarzenberg SJ, Norris AL, Fox CK, Steinberger J. Hyperleptinemia and hypoadiponectinemia in extreme pediatric obesity. Metab Syndr Relat Disord. 2012;10:123-127
14. Messiah SE, Carrillo-Iregui A, Garibay-Nieto G, Lopez-Mitnik G, Cossio S, Arheart KL. Inter- and intra-Ethnic group comparison of metabolic syndrome components among morbidly obese adolescents. J Clin Hypertens (Greenwich). 2010;12:645-652
15. Norris AL, Steinberger J, Steffen LM, Metzig AM, Schwarzenberg SJ, Kelly AS. Circulating oxidized LDL and inflammation in extreme pediatric obesity. Obesity (Silver Spring). 2011;19:1415-1419
16. Schlager O, Willfort-Ehringer A, Hammer A, Steiner S, Fritsch M, Giurgea A, Margeta C, Lilaj I, Zehetmayer S, Widhalm K, Koppensteiner R, Gschwandtner ME. Microvascular function is impaired in children with morbid obesity. Vasc Med. 2011;16:97-102
17. Tounian P, Aggoun Y, Dubern B, Varille V, Guy-Grand B, Sidi D, Girardet JP, Bonnet D. Presence of increased stiffness of the common carotid artery and endothelial dysfunction in severely obese children: A prospective study. Lancet. 2001;358:1400-1404.
18. Weiss R, Dziura J, Burgert TS, Tamborlane WV, Taksali SE, Yeckel CW, Allen K, Lopes M, Savoye M, Morrison J, Sherwin RS, Caprio S. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med. 2004;350:2362-2374
19. Baker JL, Olsen LW, Sørensen TI. Childhood body-mass index and the risk of coronary heart disease in adulthood. N Engl J Med. 2007;357:2329-2337
20. Bessonova L, Marshall SF, Ziogas A, Largent J, Bernstein L, Henderson KD, Ma H, West DW, Anton-Culver H. The association of body mass index with mortality in the California Teachers Study. Int J Cancer. 2011;129:2492-2501
21. Franks PW, Hanson RL, Knowler WC, Sievers ML, Bennett PH, Looker HC. Childhood obesity, other cardiovascular risk factors, and premature death. N Engl J Med. 2010;362:485-493
22. Juonala M, Magnussen CG, Berenson GS, Venn A, Burns TL, Sabin MA, Srinivasan SR, Daniels SR, Davis PH, Chen W, Sun C, Cheung M, Viikari JS, Dwyer T, Raitakari OT. Childhood adiposity, adult adiposity, and cardiovascular risk factors. N Engl J Med. 2011;365:1876-1885
23. Lloyd LJ, Langley-Evans SC, McMullen S. Childhood obesity and adult cardiovascular disease risk: A systematic review. Int J Obes (Lond). 2010;34:18-28
24. Ma J, Flanders WD, Ward EM, Jemal A. Body mass index in young adulthood and premature death: Analyses of the US National Health Interview Survey linked mortality files. Am J Epidemiol. 2011;174:934-944
25. Morrison JA, Friedman LA, Gray-McGuire C. Metabolic syndrome in childhood predicts adult cardiovascular disease 25 years later: The Princeton Lipid Research Clinics Follow-up Study. Pediatrics. 2007;120:340-345
26. Must A, Jacques PF, Dallal GE, Bajema CJ, Dietz WH. Long-term morbidity and mortality of overweight adolescents: A follow-up of the Harvard Growth Study of 1922 to 1935. N Engl J Med. 1992;327:1350-1355
27. Owen CG, Whincup PH, Orfei L, Chou QA, Rudnicka AR, Wathern AK, Kaye SJ, Eriksson JG, Osmond C, Cook DG. Is body mass index before middle age related to coronary heart disease risk in later life? Evidence from observational studies. Int J Obes (Lond). 2009;33:866-877
28. Park MH, Falconer C, Viner RM, Kinra S. The impact of childhood obesity on morbidity and mortality in adulthood: A systematic review. Obes Rev. 2012;13:985-1000
29. Tirosh A, Shai I, Afek A, Dubnov-Raz G, Ayalon N, Gordon B, Derazne E, Tzur D, Shamis A, Vinker S, Rudich A. Adolescent BMI trajectory and risk of diabetes versus coronary disease. N Engl J Med. 2011;364:1315-1325
30. Johnston CA, Tyler C, Palcic JL, Stansberry SA, Gallagher MR, Foreyt JP. Smaller weight changes in standardized body mass index in response to treatment as weight classification increases. J Pediatr. 2011;158:624-627
31. Kalarchian MA, Levine MD, Arslanian SA, Ewing LJ, Houck PR, Cheng Y, Ringham RM, Sheets CA, Marcus MD. Family-based treatment of severe pediatric obesity: Randomized, controlled trial. Pediatrics. 2009;124:1060-1068
32. Savoye M, Nowicka P, Shaw M, Yu S, Dziura J, Chavent G, O'Malley G, Serrecchia JB, Tamborlane WV, Caprio S. Long-term results of an obesity program in an ethnically diverse pediatric population. Pediatrics. 2011;127:402-410
33. Danielsson P, Kowalski J, Ekblom Ö, Marcus C. Response of severely obese children and adolescents to behavioral treatment. Arch Pediatr Adolesc Med. 2012;166:1103-1108
34. Barlow SE; Expert Committee. Expert committee recommendations regarding the prevention, assessment, and treatment of child and adolescent overweight and obesity: Summary report. Pediatrics. 2007;120(suppl 4):S164-S192
35. Ogden CL, Kuczmarski RJ, Flegal KM, Mei Z, Guo S, Wei R, Grummer- Strawn LM, Curtin LR, Roche AF, Johnson CL. Centers for Disease Control and Prevention 2000 growth charts for the United States: Improvements to the 1977 National Center for Health Statistics version. Pediatrics. 2002;109:45-60
36. Kuczmarski RJ, Ogden CL, Guo SS, Grummer-Strawn LM, Flegal KM, Mei Z, Wei R, Curtin LR, Roche AF, Johnson CL. 2000 CDC Growth Charts for the United States: Methods and development. Vital Health Stat 11. 2002;(246):1-190
37. Gulati AK, Kaplan DW, Daniels SR. Clinical tracking of severely obese children: A new growth chart. Pediatrics. 2012;130:1136-1140
38. Cole TJ, Bellizzi MC, Flegal KM, Dietz WH. Establishing a standard definition for child overweight and obesity worldwide: International survey. BMJ. 2000;320:1240-1243
39. Cole TJ, Faith MS, Pietrobelli A, Heo M. What is the best measure of adiposity change in growing children: BMI, BMI %, BMI z-score or BMI centile? [published correction appears in Eur J Clin Nutr. 2005l59:807] Eur J Clin Nutr. 2005;59:419-425
40. Paluch RA, Epstein LH, Roemmich JN. Comparison of methods to evaluate changes in relative body mass index in pediatric weight control. Am J Hum Biol. 2007;19:487-494
41. Berrington De Gonzalez A, Hartge P, Cerhan JR, Flint AJ, Hannan L, MacInnis RJ, Moore SC, Tobias GS, Anton-Culver H, Freeman LB, Beeson WL, Clipp SL, English DR, Folsom AR, Freedman DM, Giles G, Hakansson N, Henderson KD, Hoffman-Bolton J, Hoppin JA, Koenig KL, Lee IM, Linet MS, Park Y, Pocobelli G, Schatzkin A, Sesso HD, Weiderpass E, Willcox BJ, Wolk A, Zeleniuch-Jacquotte A, Willett WC, Thun MJ. Body-mass index and mortality among 1.46 million white adults [published correction appears in N Engl J Med. 2011;365:869]. N Engl J Med. 2010;363:2211-2219
42. Cockrell Skinner A, Perrin EM, Steiner MJ. Healthy for now? A crosssectional study of the comorbidities in obese preschool children in the United States. Clin Pediatr (Phila). 2010;49:648-655
43. Marcus MD, Baranowski T, DeBar LL, Edelstein S, Kaufman FR, Schneider M, Siega-Riz AM, Staten MA, Virus A, Yin Z. Severe obesity and selected risk factors in a sixth grade multiracial cohort: The HEALTHY study. J Adolesc Health. 2010;47:604-607
44. Nadler EP, Brotman LM, Miyoshi T, Fryer GE Jr, Weitzman M. Morbidity in obese adolescents who meet the adult National Institutes of Health criteria for bariatric surgery. J Pediatr Surg. 2009;44:1869-1876
45. Ogden CL, Carroll MD, Flegal KM. High body mass index for age among US children and adolescents, 2003-2006. JAMA. 2008;299:2401-2405
46. Ogden CL, Lamb MM, Carroll MD, Flegal KM. Obesity and socioeconomic status in children and adolescents: United States, 2005-2008. NCHS Data Brief. 2010;(51):1-8
47. Steinberger J, Daniels SR. Obesity, insulin resistance, diabetes, and cardiovascular risk in children: An American Heart Association scientific statement from the Atherosclerosis, Hypertension, and Obesity in the Young Committee (Council on Cardiovascular Disease in the Young) and the Diabetes Committee (Council on Nutrition, Physical Activity, and Metabolism). Circulation. 2003;107:1448-1453
48. Steinberger J, Daniels SR, Eckel RH, Hayman L, Lustig RH, McCrindle B, Mietus-Snyder ML. Progress and challenges in metabolic syndrome in children and adolescents: A scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in the Young Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular Nursing; and Council on Nutrition, Physical Activity, and Metabolism. Circulation. 2009;119:628-647
49. Balagopal PB, De Ferranti SD, Cook S, Daniels SR, Gidding SS, Hayman LL, McCrindle BW, Mietus-Snyder ML, Steinberger J; on behalf of the American Heart Association Committee on Atherosclerosis Hypertension and Obesity in Youth of the Council on Cardiovascular Disease in the Young; Council on Nutrition, Physical Activity and Metabolism; Council on Epidemiology and Prevention. Nontraditional risk factors and biomarkers for cardiovascular disease: Mechanistic, research, and clinical considerations for youth: A scientific statement from the American Heart Association. Circulation. 2011;123:2749-2769
50. Burns TL, Moll PP, Lauer RM. The relation between ponderosity and coronary risk factors in children and their relatives: The Muscatine Ponderosity Family Study. Am J Epidemiol. 1989;129:973-987
51. Hayman LL, Meininger JC, Coates PM, Gallagher PR. Nongenetic influences of obesity on risk factors for cardiovascular disease during two phases of development. Nurs Res. 1995;44:277-283
52. Kikuchi DA, Srinivasan SR, Harsha DW, Webber LS, Sellers TA, Berenson GS. Relation of serum lipoprotein lipids and apolipoproteins to obesity in children: The Bogalusa Heart Study. Prev Med. 1992;21:177-190
53. Morrison JA, Sprecher DL, Barton BA, Waclawiw MA, Daniels SR. Overweight, fat patterning, and cardiovascular disease risk factors in black and white girls: The National Heart, Lung, and Blood Institute Growth and Health Study. J Pediatr. 1999;135:458-464
54. Morrison JA, Barton BA, Biro FM, Daniels SR, Sprecher DL. Overweight, fat patterning, and cardiovascular disease risk factors in black and white boys. J Pediatr. 1999;135:451-457
55. Muntner P, He J, Cutler JA, Wildman RP, Whelton PK. Trends in blood pressure among children and adolescents. JAMA. 2004;291:2107-2113
56. Arslanian S, Suprasongsin C. Insulin sensitivity, lipids, and body composition in childhood: Is syndrome X present? J Clin Endocrinol Metab. 1996;81:1058-1062
57. Caprio S. Insulin resistance in childhood obesity. J Pediatr Endocrinol Metab. 2002;15(suppl 1):487-492
58. Sinaiko AR, Steinberger J, Moran A, Prineas RJ, Vessby B, Basu S, Tracy R, Jacobs DR Jr. Relation of body mass index and insulin resistance to cardiovascular risk factors, inflammatory factors, and oxidative stress during adolescence. Circulation. 2005;111:1985-1991
59. Cook DG, Mendall MA, Whincup PH, Carey IM, Ballam L, Morris JE, Miller GJ, Strachan DP. C-reactive protein concentration in children: Relationship to adiposity and other cardiovascular risk factors. Atherosclerosis. 2000;149:139-150
60. Urbina EM, Kimball TR, McCoy CE, Khoury PR, Daniels SR, Dolan LM. Youth with obesity and obesity-related type 2 diabetes mellitus demonstrate abnormalities in carotid structure and function. Circulation. 2009;119:2913-2919
61. Urbina EM, Kimball TR, Khoury PR, Daniels SR, Dolan LM. Increased arterial stiffness is found in adolescents with obesity or obesity-related type 2 diabetes mellitus. J Hypertens. 2010;28:1692-1698
62. Meyer AA, Kundt G, Steiner M, Schuff-Werner P, Kienast W. Impaired flow-mediated vasodilation, carotid artery intima-media thickening, and elevated endothelial plasma markers in obese children: The impact of cardiovascular risk factors. Pediatrics. 2006;117:1560-1567
63. Cook S, Weitzman M, Auinger P, Nguyen M, Dietz WH. Prevalence of a metabolic syndrome phenotype in adolescents: Findings from the third National Health and Nutrition Examination Survey, 1988-1994. Arch Pediatr Adolesc Med. 2003;157:821-827
64. Berenson GS, Srinivasan SR, Bao W, Newman WP 3rd, Tracy RE, Wattigney WA. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults: The Bogalusa Heart Study. N Engl J Med. 1998;338:1650-1656
65. McGill HC Jr, McMahan CA, Zieske AW, Tracy RE, Malcom GT, Herderick EE, Strong JP. Association of coronary heart disease risk factors with microscopic qualities of coronary atherosclerosis in youth. Circulation. 2000;102:374-379
66. McGill HC Jr, McMahan CA, Zieske AW, Sloop GD, Walcott JV, Troxclair DA, Malcom GT, Tracy RE, Oalmann MC, Strong JP; Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Associations of coronary heart disease risk factors with the intermediate lesion of atherosclerosis in youth. Arterioscler Thromb Vasc Biol. 2000;20:1998-2004
67. McGill HC Jr, McMahan CA, Herderick EE, Zieske AW, Malcom GT, Tracy RE, Strong JP; Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Obesity accelerates the progression of coronary atherosclerosis in young men. Circulation. 2002;105:2712-2718
68. Ridker PM, Buring JE, Cook NR, Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: An 8-year follow-up of 14 719 initially healthy American women. Circulation. 2003;107:391-397
69. Sabatine MS, Morrow DA, Jablonski KA, Rice MM, Warnica JW, Domanski MJ, Hsia J, Gersh BJ, Rifai N, Ridker PM, Pfeffer MA, Braunwald E; PEACE Investigators. Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease. Circulation. 2007;115:1528-1536
70. Yui S, Sasaki T, Miyazaki A, Horiuchi S, Yamazaki M. Induction of murine macrophage growth by modified LDLs. Arterioscler Thromb. 1993;13:331-337
71. Obert P, Gueugnon C, Nottin S, Vinet A, Gayrard S, Rupp T, Dumoulin G, Tordi N, Mougin F. Two-Dimensional strain and twist by vector velocity imaging in adolescents with severe obesity. Obesity (Silver Spring). 2012;20:2397-2405
72. Daniels SR, Witt SA, Glascock B, Khoury PR, Kimball TR. Left atrial size in children with hypertension: The influence of obesity, blood pressure, and left ventricular mass. J Pediatr. 2002;141:186-190
73. Ippisch HM, Inge TH, Daniels SR, Wang B, Khoury PR, Witt SA, Glascock BJ, Garcia VF, Kimball TR. Reversibility of cardiac abnormalities in morbidly obese adolescents. J Am Coll Cardiol. 2008;51:1342-1348
74. Crowley DI, Khoury PR, Urbina EM, Ippisch HM, Kimball TR. Cardiovascular impact of the pediatric obesity epidemic: Higher left ventricular mass is related to higher body mass index. J Pediatr. 2011;158:709-714.e1
75. Janz KF, Dawson JD, Mahoney LT. Predicting heart growth during puberty: The Muscatine Study. Pediatrics. 2000;105:E63
76. Urbina EM, Gidding SS, Bao W, Pickoff AS, Berdusis K, Berenson GS. Effect of body size, ponderosity, and blood pressure on left ventricular growth in children and young adults in the Bogalusa Heart Study. Circulation. 1995;91:2400-2406
77. Invitti C, Guzzaloni G, Gilardini L, Morabito F, Viberti G. Prevalence and concomitants of glucose intolerance in European obese children and adolescents. Diabetes Care. 2003;26:118-124
78. Sinha R, Fisch G, Teague B, Tamborlane WV, Banyas B, Allen K, Savoye M, Rieger V, Taksali S, Barbetta G, Sherwin RS, Caprio S. Prevalence of impaired glucose tolerance among children and adolescents with marked obesity [published correction appears in N Engl J Med. 2002;346:1756. Dosage error in published abstract; MEDLINE/PubMed abstract corrected; dosage error in article text]. N Engl J Med. 2002;346:802-810
79. Lawson ML, Kirk S, Mitchell T, Chen MK, Loux TJ, Daniels SR, Harmon CM, Clements RH, Garcia VF, Inge TH; Pediatric Bariatric Study Group. One-year outcomes of Roux-En-Y gastric bypass for morbidly obese adolescents: A multicenter study from the Pediatric Bariatric Study Group. J Pediatr Surg. 2006;41:137-143
80. Reinehr T, Wabitsch M, Kleber M, De Sousa G, Denzer C, Toschke AM. Parental diabetes, pubertal stage, and extreme obesity are the main risk factors for prediabetes in children and adolescents: A simple risk score to identify children at risk for prediabetes. Pediatr Diabetes. 2009;10:395-400
81. Weiss R, Taksali SE, Tamborlane WV, Burgert TS, Savoye M, Caprio S. Predictors of changes in glucose tolerance status in obese youth. Diabetes Care. 2005;28:902-909
82. Lafortuna CL, Adorni F, Agosti F, De Col A, Sievert K, Siegfried W, Sartorio A. Prevalence of the metabolic syndrome among extremely obese adolescents in Italy and Germany. Diabetes Res Clin Pract. 2010;88:14-21
83. Verhulst SL, Schrauwen N, Haentjens D, Suys B, Rooman RP, Van Gaal L, De Backer WA, Desager KN. Sleep-Disordered breathing in overweight and obese children and adolescents: Prevalence, characteristics and the role of fat distribution. Arch Dis Child. 2007;92:205-208
84. Chay OM, Goh A, Abisheganaden J, Tang J, Lim WH, Chan YH, Wee MK, Johan A, John AB, Cheng HK, Lin M, Chee T, Rajan U, Wang S, Machin D. Obstructive sleep apnea syndrome in obese Singapore children. Pediatr Pulmonol. 2000;29:284-290
85. Marcus CL, Curtis S, Koerner CB, Joffe A, Serwint JR, Loughlin GM. Evaluation of pulmonary function and polysomnography in obese children and adolescents. Pediatr Pulmonol. 1996;21:176-183
86. Gislason T, Benediktsdóttir B. Snoring, apneic episodes, and nocturnal hypoxemia among children 6 months to 6 years old: An epidemiologic study of lower limit of prevalence. Chest. 1995;107:963-966
87. Schlaud M, Urschitz MS, Urschitz-Duprat PM, Poets CF. The German study on sleep-Disordered breathing in primary school children: Epidemiological approach, representativeness of study sample, and preliminary screening results. Paediatr Perinat Epidemiol. 2004;18:431-440
88. Shine NP, Coates HL, Lannigan FJ. Obstructive sleep apnea, morbid obesity, and adenotonsillar surgery: A review of the literature. Int J Pediatr Otorhinolaryngol. 2005;69:1475-1482
89. Gozal D, Kheirandish-Gozal L. Obesity and excessive daytime sleepiness in prepubertal children with obstructive sleep apnea. Pediatrics. 2009;123:13-18
90. Mitchell RB, Kelly J. Outcome of adenotonsillectomy for obstructive sleep apnea in obese and normal-weight children. Otolaryngol Head Neck Surg. 2007;137:43-48
91. Kalra M, Inge T. Effect of bariatric surgery on obstructive sleep apnoea in adolescents. Paediatr Respir Rev. 2006;7:260-267
92. Mallory GB Jr, Fiser DH, Jackson R. Sleep-associated breathing disorders in morbidly obese children and adolescents. J Pediatr. 1989;115:892-897
93. Redline S, Tishler PV, Schluchter M, Aylor J, Clark K, Graham G. Risk factors for sleep-Disordered breathing in children: Associations with obesity, race, and respiratory problems. Am J Respir Crit Care Med. 1999;159(pt 1):1527-1532
94. Kohler MJ, Thormaehlen S, Kennedy JD, Pamula Y, van den Heuvel CJ, Lushington K, Martin AJ. Differences in the association between obesity and obstructive sleep apnea among children and adolescents. J Clin Sleep Med. 2009;5:506-511
95. Charlton M. Nonalcoholic fatty liver disease: A review of current understanding and future impact. Clin Gastroenterol Hepatol. 2004;2:1048-1058
96. Younossi ZM, Diehl AM, Ong JP. Nonalcoholic fatty liver disease: An agenda for clinical research. Hepatology. 2002;35:746-752
97. Molleston JP, White F, Teckman J, Fitzgerald JF. Obese children with steatohepatitis can develop cirrhosis in childhood. Am J Gastroenterol. 2002;97:2460-2462
98. Rashid M, Roberts EA. Nonalcoholic steatohepatitis in children. J Pediatr Gastroenterol Nutr. 2000;30:48-53
99. Schwimmer JB, Deutsch R, Rauch JB, Behling C, Newbury R, Lavine JE. Obesity, insulin resistance, and other clinicopathological correlates of pediatric nonalcoholic fatty liver disease. J Pediatr. 2003;143:500-505
100. Schwimmer JB, Behling C, Newbury R, Deutsch R, Nievergelt C, Schork NJ, Lavine JE. Histopathology of pediatric nonalcoholic fatty liver disease. Hepatology. 2005;42:641-649
101. Jonas MM, Krawczuk LE, Kim HB, Lillehei C, Perez-Atayde A. Rapid recurrence of nonalcoholic fatty liver disease after transplantation in a child with hypopituitarism and hepatopulmonary syndrome. Liver Transpl. 2005;11:108-110
102. Sagi R, Reif S, Neuman G, Webb M, Phillip M, Shalitin S. Nonalcoholic fatty liver disease in overweight children and adolescents. Acta Paediatr. 2007;96:1209-1213
103. Xanthakos S, Miles L, Bucuvalas J, Daniels S, Garcia V, Inge T. Histologic spectrum of nonalcoholic fatty liver disease in morbidly obese adolescents. Clin Gastroenterol Hepatol. 2006;4:226-232
104. Sartorio A, Del Col A, Agosti F, Mazzilli G, Bellentani S, Tiribelli C, Bedogni G. Predictors of non-alcoholic fatty liver disease in obese children. Eur J Clin Nutr. 2007;61:877-883
105. Taylor ED, Theim KR, Mirch MC, Ghorbani S, Tanofsky-Kraff M, Adler- Wailes DC, Brady S, Reynolds JC, Calis KA, Yanovski JA. Orthopedic complications of overweight in children and adolescents. Pediatrics. 2006;117:2167-2174
106. Montgomery CO, Young KL, Austen M, Jo CH, Blasier RD, Ilyas M. Increased risk of Blount disease in obese children and adolescents with vitamin D deficiency. J Pediatr Orthop. 2010;30:879-882
107. Bowen JR, Assis M, Sinha K, Hassink S, Littleton A. Associations among slipped capital femoral epiphysis, tibia vara, and type 2 juvenile diabetes. J Pediatr Orthop. 2009;29:341-344
108. Bhatia NN, Pirpiris M, Otsuka NY. Body mass index in patients with slipped capital femoral epiphysis. J Pediatr Orthop. 2006;26:197-199
109. Schwimmer JB, Burwinkle TM, Varni JW. Health-related quality of life of severely obese children and adolescents. JAMA. 2003;289:1813-1819
110. Zeller MH, Roehrig HR, Modi AC, Daniels SR, Inge TH. Health-related quality of life and depressive symptoms in adolescents with extreme obesity presenting for bariatric surgery. Pediatrics. 2006;117:1155-1161
111. Goodman E, Must A. Depressive symptoms in severely obese compared with normal weight adolescents: Results from a community-based longitudinal study. J Adolesc Health. 2011;49:64-69
112. Tanofsky-Kraff M, Yanovski SZ, Wilfley DE, Marmarosh C, Morgan CM, Yanovski JA. Eating-Disordered behaviors, body fat, and psychopathology in overweight and normal-weight children. J Consult Clin Psychol. 2004;72:53-61
113. Eddy KT, Tanofsky-Kraff M, Thompson-Brenner H, Herzog DB, Brown TA, Ludwig DS. Eating disorder pathology among overweight treatmentseeking youth: Clinical correlates and cross-sectional risk modeling. Behav Res Ther. 2007;45:2360-2371
114. Wildes JE, Marcus MD, Kalarchian MA, Levine MD, Houck PR, Cheng Y. Self-reported binge eating in severe pediatric obesity: Impact on weight change in a randomized controlled trial of family-based treatment. Int J Obes (Lond). 2010;34:1143-1148
115. Goossens L, Braet C, Decaluwé V. Loss of control over eating in obese youngsters. Behav Res Ther. 2007;45:1-9
116. Wilfley D, Berkowitz R, Goebel-Fabbri A, Hirst K, Ievers-Landis C, Lipman TH, Marcus M, Ng D, Pham T, Saletsky R, Schanuel J, Van Burn D. Binge eating, mood, and quality of life in youth with type 2 diabetes: Baseline data from the TODAY study. Diabetes Care 2011;34:858-860
117. Freedman DS, Shear CL, Burke GL, Srinivasan SR, Webber LS, Harsha DW, Berenson GS. Persistence of juvenile-onset obesity over eight years: The Bogalusa Heart Study. Am J Public Health. 1987;77:588-592
118. Freedman DS, Khan LK, Serdula MK, Dietz WH, Srinivasan SR, Berenson GS. The relation of childhood BMI to adult adiposity: The Bogalusa Heart Study. Pediatrics. 2005;115:22-27
119. Mahoney LT, Lauer RM, Lee J, Clarke WR. Factors affecting tracking of coronary heart disease risk factors in children: The Muscatine Study. Ann N Y Acad Sci. 1991;623:120-132
120. Fuentes RM, Notkola IL, Shemeikka S, Tuomilehto J, Nissinen A. Tracking of body mass index during childhood: A 15-year prospective population-based family study in eastern Finland. Int J Obes Relat Metab Disord. 2003;27:716-721
121. Kvaavik E, Tell GS, Klepp KI. Predictors and tracking of body mass index from adolescence into adulthood: Follow-up of 18 to 20 years in the Oslo Youth Study. Arch Pediatr Adolesc Med. 2003;157:1212-1218
122. Julia M, van Weissenbruch MM, Prawirohartono EP, Surjono A, Delemarre-Van De Waal HA. Tracking for underweight, overweight and obesity from childhood to adolescence: A 5-year follow-up study in urban Indonesian children. Horm Res. 2008;69:301-306
123. Wang Y, Ge K, Popkin BM. Tracking of body mass index from childhood to adolescence: A 6-y follow-up study in China. Am J Clin Nutr. 2000;72:1018-1024
124. Bao W, Threefoot SA, Srinivasan SR, Berenson GS. Essential hypertension predicted by tracking of elevated blood pressure from childhood to adulthood: The Bogalusa Heart Study. Am J Hypertens. 1995;8:657-665
125. Burke V, Beilin LJ, Dunbar D. Tracking of blood pressure in Australian children. J Hypertens. 2001;19:1185-1192
126. Lauer RM, Anderson AR, Beaglehole R, Burns TL. Factors related to tracking of blood pressure in children. U.S. National Center for Health Statistics Health Examination Surveys Cycles II and III. Hypertension. 1984;6:307-314
127. Kaitosaari T, Simell O, Viikari J, Raitakari O, Siltala M, Hakanen M, Leino A, Jokinen E, Rönnemaa T. Tracking and determinants of LDL particle size in healthy children from 7 to 11 years of age: The STRIP Study. Eur J Pediatr. 2009;168:531-539
128. Porkka KV, Viikari JS, Akerblom HK. Tracking of serum HDL-cholesterol and other lipids in children and adolescents: The Cardiovascular Risk in Young Finns Study. Prev Med. 1991;20:713-724
129. Webber LS, Srinivasan SR, Wattigney WA, Berenson GS. Tracking of serum lipids and lipoproteins from childhood to adulthood: The Bogalusa Heart Study. Am J Epidemiol. 1991;133:884-899
130. Sinaiko AR, Donahue RP, Jacobs DR Jr, Prineas RJ. Relation of weight and rate of increase in weight during childhood and adolescence to body size, blood pressure, fasting insulin, and lipids in young adults: The Minneapolis Childreńs Blood Pressure Study. Circulation. 1999;99:1471-1476
131. Rademacher ER, Jacobs DR Jr, Moran A, Steinberger J, Prineas RJ, Sinaiko A. Relation of blood pressure and body mass index during childhood to cardiovascular risk factor levels in young adults. J Hypertens. 2009;27:1766-1774
132. Srinivasan SR, Myers L, Berenson GS. Changes in metabolic syndrome variables since childhood in prehypertensive and hypertensive subjects: The Bogalusa Heart Study. Hypertension. 2006;48:33-39
133. Freedman DS, Khan LK, Dietz WH, Srinivasan SR, Berenson GS. Relationship of childhood obesity to coronary heart disease risk factors in adulthood: The Bogalusa Heart Study. Pediatrics. 2001;108:712-718
134. Patel DA, Srinivasan SR, Xu JH, Chen W, Berenson GS. Persistent elevation of liver function enzymes within the reference range is associated with increased cardiovascular risk in young adults: The Bogalusa Heart Study. Metabolism. 2007;56:792-798
135. Morrison JA, Glueck CJ, Daniels S, Wang P. Determinants of persistent obesity and hyperinsulinemia in a biracial cohort: A 15-year prospective study of schoolgirls. J Pediatr. 2010;157:559-565
136. Huang TT, Nansel TR, Belsheim AR, Morrison JA. Sensitivity, specificity, and predictive values of pediatric metabolic syndrome components in relation to adult metabolic syndrome: The Princeton LRC follow-up study. J Pediatr. 2008;152:185-190
137. Mattsson N, Rönnemaa T, Juonala M, Viikari JS, Raitakari OT. Childhood predictors of the metabolic syndrome in adulthood: The Cardiovascular Risk in Young Finns Study. Ann Med. 2008;40:542-552
138. Srinivasan SR, Myers L, Berenson GS. Predictability of childhood adiposity and insulin for developing insulin resistance syndrome (syndrome X) in young adulthood: The Bogalusa Heart Study. Diabetes. 2002;51:204-209
139. Toprak D, Toprak A, Chen W, Xu JH, Srinivasan S, Berenson GS. Adiposity in childhood is related to C-reactive protein and adiponectin in young adulthood: From the Bogalusa Heart Study. Obesity (Silver Spring). 2011;19:185-190
140. Narayan KM, Boyle JP, Thompson TJ, Gregg EW, Williamson DF. Effect of BMI on lifetime risk for diabetes in the U.S. Diabetes Care. 2007;30:1562-1566
141. Magnussen CG, Koskinen J, Chen W, Thomson R, Schmidt MD, Srinivasan SR, Kivimäki M, Mattsson N, Kähönen M, Laitinen T, Taittonen L, Rönnemaa T, Viikari JS, Berenson GS, Juonala M, Raitakari OT. Pediatric metabolic syndrome predicts adulthood metabolic syndrome, subclinical atherosclerosis, and type 2 diabetes mellitus but is no better than body mass index alone: The Bogalusa Heart Study and the Cardiovascular Risk in Young Finns Study. Circulation. 2010;122:1604-1611
142. Franks PW, Hanson RL, Knowler WC, Moffett C, Enos G, Infante AM, Krakoff J, Looker HC. Childhood predictors of young-onset type 2 diabetes. Diabetes. 2007;56:2964-2972
143. McCance DR, Pettitt DJ, Hanson RL, Jacobsson LT, Bennett PH, Knowler WC. Glucose, insulin concentrations and obesity in childhood and adolescence as predictors of NIDDM. Diabetologia. 1994;37:617-623
144. Morrison JA, Friedman LA, Wang P, Glueck CJ. Metabolic syndrome in childhood predicts adult metabolic syndrome and type 2 diabetes mellitus 25 to 30 years later. J Pediatr. 2008;152:201-206
145. Nguyen QM, Srinivasan SR, Xu JH, Chen W, Berenson GS. Changes in risk variables of metabolic syndrome since childhood in pre-Diabetic and type 2 diabetic subjects: The Bogalusa Heart Study. Diabetes Care. 2008;31:2044-2049
146. Nguyen QM, Srinivasan SR, Xu JH, Chen W, Kieltyka L, Berenson GS. Utility of childhood glucose homeostasis variables in predicting adult diabetes and related cardiometabolic risk factors: The Bogalusa Heart Study. Diabetes Care. 2010;33:670-675
147. Thearle MS, Bunt JC, Knowler WC, Krakoff J. Childhood predictors of adult acute insulin response and insulin action. Diabetes Care. 2009;32:938-943
148. Yeung EH, Zhang C, Louis GM, Willett WC, Hu FB. Childhood size and life course weight characteristics in association with the risk of incident type 2 diabetes. Diabetes Care. 2010;33:1364-1369
149. Li X, Li S, Ulusoy E, Chen W, Srinivasan SR, Berenson GS. Childhood adiposity as a predictor of cardiac mass in adulthood: The Bogalusa Heart Study. Circulation. 2004;110:3488-3492
150. Haji SA, Ulusoy RE, Patel DA, Srinivasan SR, Chen W, Delafontaine P, Berenson GS. Predictors of left ventricular dilatation in young adults (from the Bogalusa Heart Study). Am J Cardiol. 2006;98:1234-1237
151. Toprak A, Wang H, Chen W, Paul T, Srinivasan S, Berenson G. Relation of childhood risk factors to left ventricular hypertrophy (eccentric or concentric) in relatively young adulthood (from the Bogalusa Heart Study). Am J Cardiol. 2008;101:1621-1625
152. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med. 1991;114:345-352
153. Juonala M, Magnussen CG, Venn A, Dwyer T, Burns TL, Davis PH, Chen W, Srinivasan SR, Daniels SR, Kähönen M, Laitinen T, Taittonen L, Berenson GS, Viikari JS, Raitakari OT. Influence of age on associations between childhood risk factors and carotid intima-media thickness in adulthood: The Cardiovascular Risk in Young Finns Study, the Childhood Determinants of Adult Health Study, the Bogalusa Heart Study, and the Muscatine Study for the International Childhood Cardiovascular Cohort (i3C) Consortium. Circulation. 2010;122:2514-2520
154. Aatola H, Hutri-Kähönen N, Juonala M, Viikari JS, Hulkkonen J, Laitinen T, Taittonen L, Lehtimäki T, Raitakari OT, Kähönen M. Lifetime risk factors and arterial pulse wave velocity in adulthood: The cardiovascular risk in young Finns study. Hypertension. 2010;55:806-811
155. Juonala M, Järvisalo MJ, Mäki-Torkko N, Kähönen M, Viikari JS, Raitakari OT. Risk factors identified in childhood and decreased carotid artery elasticity in adulthood: The Cardiovascular Risk in Young Finns Study. Circulation. 2005;112:1486-1493
156. Juonala M, Raitakari M, S A Viikari J, Raitakari OT. Obesity in youth is not an independent predictor of carotid IMT in adulthood: The Cardiovascular Risk in Young Finns Study. Atherosclerosis. 2006;185:388-393
157. Raitakari OT, Juonala M, Viikari JS. Obesity in childhood and vascular changes in adulthood: Insights into the Cardiovascular Risk in Young Finns Study. Int J Obes (Lond). 2005;29(suppl 2):S101-S104
158. Juonala M, Viikari JS, Kähönen M, Taittonen L, Laitinen T, Hutri- Kähönen N, Lehtimäki T, Jula A, Pietikäinen M, Jokinen E, Telama R, Räsänen L, Mikkilä V, Helenius H, Kivimäki M, Raitakari OT. Lifetime risk factors and progression of carotid atherosclerosis in young adults: The Cardiovascular Risk in Young Finns study. Eur Heart J. 2010;31:1745-1751
159. Freedman DS, Patel DA, Srinivasan SR, Chen W, Tang R, Bond MG, Berenson GS. The contribution of childhood obesity to adult carotid intima-media thickness: The Bogalusa Heart Study. Int J Obes (Lond). 2008;32:749-756
160. Oren A, Vos LE, Uiterwaal CS, Gorissen WH, Grobbee DE, Bots ML. Change in body mass index from adolescence to young adulthood and increased carotid intima-media thickness at 28 years of age: The Atherosclerosis Risk in Young Adults study. Int J Obes Relat Metab Disord. 2003;27:1383-1390
161. Freedman DS, Dietz WH, Tang R, Mensah GA, Bond MG, Urbina EM, Srinivasan S, Berenson GS. The relation of obesity throughout life to carotid intima-media thickness in adulthood: The Bogalusa Heart Study. Int J Obes Relat Metab Disord. 2004;28:159-166.
162. Lawlor DA, Martin RM, Gunnell D, Galobardes B, Ebrahim S, Sandhu J, Ben-Shlomo Y, McCarron P, Davey Smith G. Association of body mass index measured in childhood, adolescence, and young adulthood with risk of ischemic heart disease and stroke: Findings from 3 historical cohort studies. Am J Clin Nutr. 2006;83:767-773
163. Stuart RB. Behavioral control of overeating. 1967. Obes Res. 1996;4:411-417
164. Epstein LH, Paluch RA, Roemmich JN, Beecher MD. Family-based obesity treatment, then and now: Twenty-five years of pediatric obesity treatment. Health Psychol. 2007;26:381-391
165. Wadden TA, Crerand CE, Brock J. Behavioral treatment of obesity. Psychiatr Clin North Am. 2005;28:151-70, ix.
166. Epstein LH, Valoski A, Wing RR, McCurley J. Ten-year follow-up of behavioral, family-based treatment for obese children. JAMA. 1990;264:2519-2523
167. Epstein LH, Valoski A, Wing RR, McCurley J. Ten-year outcomes of behavioral family-based treatment for childhood obesity. Health Psychol. 1994;13:373-383
168. Epstein LH, Roemmich JN, Raynor HA. Behavioral therapy in the treatment of pediatric obesity. Pediatr Clin North Am. 2001;48:981-993
169. Wrotniak BH, Epstein LH, Paluch RA, Roemmich JN. The relationship between parent and child self-reported adherence and weight loss. Obes Res. 2005;13:1089-1096
170. Levine MD, Ringham RM, Kalarchian MA, Wisniewski L, Marcus MD. Is family-based behavioral weight control appropriate for severe pediatric obesity? Int J Eat Disord. 2001;30:318-328
171. August GP, Caprio S, Fennoy I, Freemark M, Kaufman FR, Lustig RH, Silverstein JH, Speiser PW, Styne DM, Montori VM; Endocrine Society. Prevention and treatment of pediatric obesity: An Endocrine Society clinical practice guideline based on expert opinion. J Clin Endocrinol Metab. 2008;93:4576-4599
172. Dietz WH, Robinson TN. Clinical practice: Overweight children and adolescents. N Engl J Med. 2005;352:2100-2109
173. Kamath CC, Vickers KS, Ehrlich A, McGovern L, Johnson J, Singhal V, Paulo R, Hettinger A, Erwin PJ, Montori VM. Clinical review: Behavioral interventions to prevent childhood obesity: A systematic review and metaanalyses of randomized trials. J Clin Endocrinol Metab. 2008;93:4606-4615
174. McGovern L, Johnson JN, Paulo R, Hettinger A, Singhal V, Kamath C, Erwin PJ, Montori VM. Clinical review: Treatment of pediatric obesity: A systematic review and meta-analysis of randomized trials. J Clin Endocrinol Metab. 2008;93:4600-4605
175. Whitlock EP, O'Connor EA, Williams SB, Beil TL, Lutz KW. Effectiveness of weight management interventions in children: A targeted systematic review for the USPSTF. Pediatrics. 2010;125:e396-E418
176. Savoye M, Shaw M, Dziura J, Tamborlane WV, Rose P, Guandalini C, Goldberg-Gell R, Burgert TS, Cali AM, Weiss R, Caprio S. Effects of a weight management program on body composition and metabolic parameters in overweight children: A randomized controlled trial. JAMA. 2007;297:2697-2704
177. Knöpfli BH, Radtke T, Lehmann M, Schätzle B, Eisenblätter J, Gachnang A, Wiederkehr P, Hammer J, Brooks-Wildhaber J. Effects of a multidisciplinary inpatient intervention on body composition, aerobic fitness, and quality of life in severely obese girls and boys. J Adolesc Health. 2008;42:119-127
178. Rolland-Cachera MF, Thibault H, Souberbielle JC, Soulié D, Carbonel P, Deheeger M, Roinsol D, Longueville E, Bellisle F, Serog P. Massive obesity in adolescents: Dietary interventions and behaviours associated with weight regain at 2 y follow-up. Int J Obes Relat Metab Disord. 2004;28:514-519
179. Berkowitz RI, Wadden TA, Gehrman CA, Bishop-Gilyard CT, Moore RH, Womble LG, Cronquist JL, Trumpikas NL, Levitt Katz LE, Xanthopoulos MS. Meal replacements in the treatment of adolescent obesity: A randomized controlled trial. Obesity (Silver Spring). 2011;19:1193-1199
180. Viner RM, Hsia Y, Neubert A, Wong IC. Rise in antiobesity drug prescribing for children and adolescents in the UK: A population-based study. Br J Clin Pharmacol. 2009;68:844-851
181. Curfman GD, Morrissey S, Drazen JM. Sibutramine: Another flawed diet pill. N Engl J Med. 2010;363:972-974
182. James WP, Caterson ID, Coutinho W, Finer N, Van Gaal LF, Maggioni AP, Torp-Pedersen C, Sharma AM, Shepherd GM, Rode RA, Renz CL; SCOUT Investigators. Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects. N Engl J Med. 2010;363:905-917
183. Chanoine JP, Hampl S, Jensen C, Boldrin M, Hauptman J. Effect of orlistat on weight and body composition in obese adolescents: A randomized controlled trial [published correction appears in JAMA. 2005;294:1491]. JAMA. 2005;293:2873-2883
184. Maahs D, De Serna DG, Kolotkin RL, Ralston S, Sandate J, Qualls C, Schade DS. Randomized, double-blind, placebo-controlled trial of orlistat for weight loss in adolescents. Endocr Pract. 2006;12:18-28
185. McDuffie JR, Calis KA, Uwaifo GI, Sebring NG, Fallon EM, Hubbard VS, Yanovski JA. Three-month tolerability of orlistat in adolescents with obesity-related comorbid conditions. Obes Res. 2002;10:642-650
186. McDuffie JR, Calis KA, Uwaifo GI, Sebring NG, Fallon EM, Frazer TE, Van Hubbard S, Yanovski JA. Efficacy of orlistat as an adjunct to behavioral treatment in overweight African American and Caucasian adolescents with obesity-related co-morbid conditions. J Pediatr Endocrinol Metab. 2004;17:307-319
187. Ozkan B, Bereket A, Turan S, Keskin S. Addition of orlistat to conventional treatment in adolescents with severe obesity. Eur J Pediatr. 2004;163:738-741
188. Viner RM, Hsia Y, Tomsic T, Wong IC. Efficacy and safety of anti-obesity drugs in children and adolescents: Systematic review and meta-analysis. Obes Rev. 2010;11:593-602
189. Wilson DM, Abrams SH, Ave T, Lee PD, Lenders C, Lustig RH, Osganian SV, Feldman HA; Glaser Pediatric Research Network Obesity Study Group. Metformin extended release treatment of adolescent obesity: A 48-week randomized, double-blind, placebo-controlled trial with 48-week follow-up. Arch Pediatr Adolesc Med 2010;164:116-123
190. Atabek ME, Pirgon O. Use of metformin in obese adolescents with hyperinsulinemia: A 6-month, randomized, double-blind, placebo-controlled clinical trial. J Pediatr Endocrinol Metab. 2008;21:339-348
191. Burgert TS, Duran EJ, Goldberg-Gell R, Dziura J, Yeckel CW, Katz S, Tamborlane WV, Caprio S. Short-term metabolic and cardiovascular effects of metformin in markedly obese adolescents with normal glucose tolerance. Pediatr Diabetes. 2008;9:567-576
192. Casteels K, Fieuws S, van Helvoirt M, Verpoorten C, Goemans N, Coudyzer W, Loeckx D, De Zegher F. Metformin therapy to reduce weight gain and visceral adiposity in children and adolescents with neurogenic or myogenic motor deficit. Pediatr Diabetes. 2010;11:61-69
193. Clarson CL, Mahmud FH, Baker JE, Clark HE, McKay WM, Schauteet VD, Hill DJ. Metformin in combination with structured lifestyle intervention improved body mass index in obese adolescents, but did not improve insulin resistance. Endocrine. 2009;36:141-146
194. Freemark M, Bursey D. The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes. Pediatrics. 2001;107:E55
195. Fu JF, Liang L, Zou CC, Hong F, Wang CL, Wang XM, Zhao ZY. Prevalence of the metabolic syndrome in Zhejiang Chinese obese children and adolescents and the effect of metformin combined with lifestyle intervention. Int J Obes (Lond). 2007;31:15-22
196. Ibáñez L, Lopez-Bermejo A, Diaz M, Marcos MV, De Zegher F. Pubertal metformin therapy to reduce total, visceral, and hepatic adiposity. J Pediatr. 2010;156:98-102.e1
197. Kay JP, Alemzadeh R, Langley G, DAngelo L, Smith P, Holshouser S. Beneficial effects of metformin in normoglycemic morbidly obese adolescents. Metabolism. 2001;50:1457-1461
198. Love-Osborne K, Sheeder J, Zeitler P. Addition of metformin to a lifestyle modification program in adolescents with insulin resistance. J Pediatr. 2008;152:817-822
199. Park MH, Kinra S, Ward KJ, White B, Viner RM. Metformin for obesity in children and adolescents: A systematic review. Diabetes Care. 2009;32:1743-1745
200. Srinivasan S, Ambler GR, Baur LA, Garnett SP, Tepsa M, Yap F, Ward GM, Cowell CT. Randomized, controlled trial of metformin for obesity and insulin resistance in children and adolescents: Improvement in body composition and fasting insulin. J Clin Endocrinol Metab. 2006;91:2074-2080
201. Yanovski JA, Krakoff J, Salaita CG, McDuffie JR, Kozlosky M, Sebring NG, Reynolds JC, Brady SM, Calis KA. Effects of metformin on body weight and body composition in obese insulin-resistant children: A randomized clinical trial. Diabetes. 2011;60:477-485
202. Kendall D, Vail A, Amin R, Barrett T, Dimitri P, Ivison F, Kibirige M, Mathew V, Matyka K, McGovern A, Stirling H, Tetlow L, Wales J, Wright N, Clayton P, Hall C. Metformin in obese children and adolescents: The MOCA trial. J Clin Endocrinol Metab. 2013;98:322-329
203. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM; Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393-403
204. Bojanowska E. Physiology and pathophysiology of glucagon-like peptide- 1 (GLP-1): The role of GLP-1 in the pathogenesis of diabetes mellitus, obesity, and stress. Med Sci Monit. 2005;11:RA271-RA278
205. Edwards CM, Stanley SA, Davis R, Brynes AE, Frost GS, Seal LJ, Ghatei MA, Bloom SR. Exendin-4 reduces fasting and postprandial glucose and decreases energy intake in healthy volunteers. Am J Physiol Endocrinol Metab. 2001;281:E155-E161
206. Kelly AS, Metzig AM, Rudser KD, Fitch AK, Fox CK, Nathan BM, Deering MM, Schwartz BL, Abuzzahab MJ, Gandrud LM, Moran A, Billington CJ, Schwarzenberg SJ. Exenatide as a weight-loss therapy in extreme pediatric obesity: A randomized, controlled pilot study. Obesity (Silver Spring). 2012;20:364-370
207. Kelly AS, Rudser KD, Nathan BM, Fox CK, Metzig AM, Coombes BJ, Fitch AK, Bomberg EM, Abuzzahab MJ. The effect of glucagon-like peptide-1 receptor agonist therapy on body mass index in adolescents with severe obesity: A randomized, placebo-controlled, clinical trial. JAMA Pediatr. 2013;167:355-360
208. Poirier P, Alpert MA, Fleisher LA, Thompson PD, Sugerman HJ, Burke LE, Marceau P, Franklin BA; on behalf of the American Heart Association Obesity Committee of Council on Nutrition, Physical Activity and Metabolism, Council on Cardiopulmonary Perioperative and Critical Care, Council on Cardiovascular Surgery and Anesthesia, Council on Cardiovascular Disease in the Young, Council on Cardiovascular Nursing, and Council on Clinical Cardiology. Cardiovascular evaluation and management of severely obese patients undergoing surgery: A science advisory from the American Heart Association. Circulation. 2009;120:86-95
209. Poirier P, Cornier MA, Mazzone T, Stiles S, Cummings S, Klein S, McCullough PA, Ren Fielding C, Franklin BA; on behalf of the American Heart Association Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Bariatric surgery and cardiovascular risk factors: A scientific statement from the American Heart Association. Circulation. 2011;123:1683-1701
210. Pallati P, Buettner S, Simorov A, Meyer A, Shaligram A, Oleynikov D. Trends in adolescent bariatric surgery evaluated by UHC database collection. Surg Endosc. 2012;26:3077-3081
211. Al-Qahtani AR. Laparoscopic adjustable gastric banding in adolescent: Safety and efficacy. J Pediatr Surg. 2007;42:894-897
212. Inge TH, Jenkins TM, Zeller M, Dolan L, Daniels SR, Garcia VF, Brandt ML, Bean J, Gamm K, Xanthakos SA. Baseline BMI is a strong predictor of nadir BMI after adolescent gastric bypass. J Pediatr. 2010;156: 103-108.e1
213. Varela JE, Hinojosa MW, Nguyen NT. Perioperative outcomes of bariatric surgery in adolescents compared with adults at academic medical centers. Surg Obes Relat Dis. 2007;3:537-540
214. De la Cruz-Muñoz N, Messiah SE, Cabrera JC, Torres C, Cuesta M, Lopez-Mitnik G, Arheart KL. Four-year weight outcomes of laparoscopic gastric bypass surgery and adjustable gastric banding among multiethnic adolescents. Surg Obes Relat Dis. 2010;6:542-547
215. Olbers T, Gronowitz E, Werling M, Mårlid S, Flodmark CE, Peltonen M, Göthberg G, Karlsson J, Ekbom K, Sjöström LV, Dahlgren J, Lönroth H, Friberg P, Marcus C. Two-year outcome of laparoscopic Roux-En-Y gastric bypass in adolescents with severe obesity: Results from a Swedish Nationwide Study (AMOS). Int J Obes (Lond). 2012;36:1388-1395
216. OBrien PE, Sawyer SM, Laurie C, Brown WA, Skinner S, Veit F, Paul E, Burton PR, McGrice M, Anderson M, Dixon JB. Laparoscopic adjustable gastric banding in severely obese adolescents: A randomized trial [published correction appears in JAMA. 2010;303:2357]. JAMA. 2010;303:519-526
217. Nadler EP, Reddy S, Isenalumhe A, Youn HA, Peck V, Ren CJ, Fielding GA. Laparoscopic adjustable gastric banding for morbidly obese adolescents affects android fat loss, resolution of comorbidities, and improved metabolic status. J Am Coll Surg. 2009;209:638-644
218. Alqahtani AR, Antonisamy B, Alamri H, Elahmedi M, Zimmerman VA. Laparoscopic sleeve gastrectomy in 108 obese children and adolescents aged 5 to 21 years. Ann Surg. 2012;256:266-273
219. Boza C, Viscido G, Salinas J, Crovari F, Funke R, Perez G. Laparoscopic sleeve gastrectomy in obese adolescents: Results in 51 patients. Surg Obes Relat Dis. 2012;8:133-137
220. Inge TH, Xanthakos SA, Zeller MH. Bariatric surgery for pediatric extreme obesity: Now or later? Int J Obes (Lond). 2007;31:1-14
221. Barnett SJ, Stanley C, Hanlon M, Acton R, Saltzman DA, Ikramuddin S, Buchwald H. Long-term follow-up and the role of surgery in adolescents with morbid obesity. Surg Obes Relat Dis. 2005;1:394-398
222. Capella JF, Capella RF. Bariatric surgery in adolescence: Is this the best age to operate? Obes Surg. 2003;13:826-832
223. Fatima J, Houghton SG, Iqbal CW, Thompson GB, Que FL, Kendrick ML, Mai JL, Collazo-Clavel ML, Sarr MG. Bariatric surgery at the extremes of age. J Gastrointest Surg. 2006;10:1392-1396
224. Papadia FS, Adami GF, Marinari GM, Camerini G, Scopinaro N. Bariatric surgery in adolescents: A long-term follow-up study. Surg Obes Relat Dis. 2007;3:465-468
225. Sugerman HJ, Sugerman EL, DeMaria EJ, Kellum JM, Kennedy C, Mowery Y, Wolfe LG. Bariatric surgery for severely obese adolescents. J Gastrointest Surg. 2003;7:102-107
226. Teeple EA, Teich S, Schuster DP, Michalsky MP. Early metabolic improvement following bariatric surgery in morbidly obese adolescents. Pediatr Blood Cancer. 2012;58:112-116
227. Sjöström L, Narbro K, Sjöström CD, Karason K, Larsson B, Wedel H, Lystig T, Sullivan M, Bouchard C, Carlsson B, Bengtsson C, Dahlgren S, Gummesson A, Jacobson P, Karlsson J, Lindroos AK, Lönroth H, Näslund I, Olbers T, Stenlöf K, Torgerson J, Agren G, Carlsson LM; Swedish Obese Subjects Study. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357:741-752
228. Kalra M, Inge T, Garcia V, Daniels S, Lawson L, Curti R, Cohen A, Amin R. Obstructive sleep apnea in extremely overweight adolescents undergoing bariatric surgery. Obes Res. 2005;13:1175-1179
229. Inge TH, Miyano G, Bean J, Helmrath M, Courcoulas A, Harmon CM, Chen MK, Wilson K, Daniels SR, Garcia VF, Brandt ML, Dolan LM. Reversal of type 2 diabetes mellitus and improvements in cardiovascular risk factors after surgical weight loss in adolescents. Pediatrics. 2009;123:214-222
230. Zeller MH, Reiter-Purtill J, Ratcliff MB, Inge TH, Noll JG. Two-year trends in psychosocial functioning after adolescent Roux-En-Y gastric bypass. Surg Obes Relat Dis. 2011;7:727-732
231. Sjöström L, Lindroos AK, Peltonen M, Torgerson J, Bouchard C, Carlsson B, Dahlgren S, Larsson B, Narbro K, Sjöström CD, Sullivan M, Wedel H; Swedish Obese Subjects Study Scientific Group. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351:2683-2693
232. Towbin A, Inge TH, Garcia VF, Roehrig HR, Clements RH, Harmon CM, Daniels SR. Beriberi after gastric bypass surgery in adolescence. J Pediatr. 2004;145:263-267
233. Treadwell JR, Sun F, Schoelles K. Systematic review and meta-analysis of bariatric surgery for pediatric obesity. Ann Surg. 2008;248:763-776
234. Jen HC, Rickard DG, Shew SB, Maggard MA, Slusser WM, Dutson EP, DeUgarte DA. Trends and outcomes of adolescent bariatric surgery in California, 2005-2007. Pediatrics. 2010;126:e746-E753
235. Kaulfers AM, Bean JA, Inge TH, Dolan LM, Kalkwarf HJ. Bone loss in adolescents after bariatric surgery. Pediatrics. 2011;127:e956-E961
236. Xanthakos SA, Inge TH. Nutritional consequences of bariatric surgery. Curr Opin Clin Nutr Metab Care. 2006;9:489-496
237. Nguyen NT, Karipineni F, Masoomi H, Laugenour K, Reavis K, Hohmann S, Varela E. Increasing utilization of laparoscopic gastric banding in the adolescent: Data from academic medical centers, 2002-2009. Am Surg. 2011;77:1510-1514
238. Zitsman JL, Digiorgi MF, Marr JR, Witt MA, Bessler M. Comparative outcomes of laparoscopic adjustable gastric banding in adolescents and adults. Surg Obes Relat Dis. 2011;7:720-726
239. Angrisani L, Favretti F, Furbetta F, Paganelli M, Basso N, Doldi SB, Iuppa A, Lucchese M, Lattuada E, Lesti G, Capizzi FD, Giardiello C, Di Lorenzo N, Veneziani A, Alkilani M, Puglisi F, Gardinazzi A, Cascardo A, Borrelli V, Lorenzo M. Obese teenagers treated by Lap-Band System: The Italian experience. Surgery. 2005;138:877-881
240. Yitzhak A, Mizrahi S, Avinoach E. Laparoscopic gastric banding in adolescents. Obes Surg. 2006;16:1318-1322
241. Himpens J, Cadière GB, Bazi M, Vouche M, Cadière B, Dapri G. Longterm outcomes of laparoscopic adjustable gastric banding. Arch Surg. 2011;146:802-807
242. Pratt JS, Lenders CM, Dionne EA, Hoppin AG, Hsu GL, Inge TH, Lawlor DF, Marino MF, Meyers AF, Rosenblum JL, Sanchez VM. Best practice updates for pediatric/adolescent weight loss surgery. Obesity (Silver Spring). 2009;17:901-910
243. Inge TH, Zeller M, Harmon C, Helmrath M, Bean J, Modi A, Horlick M, Kalra M, Xanthakos S, Miller R, Akers R, Courcoulas A. Teen- Longitudinal Assessment of Bariatric Surgery: Methodological features of the first prospective multicenter study of adolescent bariatric surgery. J Pediatr Surg. 2007;42:1969-1971
244. Pratt CA, Stevens J, Daniels S. Childhood obesity prevention and treatment: Recommendations for future research. Am J Prev Med. 2008;35:249-252
245. Rhodes ET, Ludwig DS. Childhood obesity as a chronic disease: Keeping the weight off. JAMA. 2007;298:1695-1696
246. Wadden TA, West DS, Neiberg RH, Wing RR, Ryan DH, Johnson KC, Foreyt JP, Hill JO, Trence DL, Vitolins MZ; Look AHEAD Research Group. One-year weight losses in the Look AHEAD study: Factors associated with success. Obesity (Silver Spring). 2009;17:713-722
247. Wilfley DE, Stein RI, Saelens BE, Mockus DS, Matt GE, Hayden-Wade HA, Welch RR, Schechtman KB, Thompson PA, Epstein LH. Efficacy of maintenance treatment approaches for childhood overweight: A randomized controlled trial. JAMA. 2007;298:1661-1673
248. Wilfley DE, Tibbs TL, Van Buren DJ, Reach KP, Walker MS, Epstein LH. Lifestyle interventions in the treatment of childhood overweight: A meta-analytic review of randomized controlled trials. Health Psychol. 2007;26:521-532
249. Skelton JA, Goff DC Jr, Ip E, Beech BM. Attrition in a Multidisciplinary Pediatric Weight Management Clinic. Child Obes. 2011;7:185-193
250. Skelton JA, Irby MB, Beech BM, Rhodes SD. Attrition and family participation in obesity treatment programs: Clinicians perceptions. Acad Pediatr. 2012;12:420-428
251. Gardin JM, Schumacher D, Constantine G, Davis KD, Leung C, Reid CL. Valvular abnormalities and cardiovascular status following exposure to dexfenfluramine or phentermine/fenfluramine. JAMA. 2000;283:1703-1709
252. Gadde KM, Allison DB, Ryan DH, Peterson CA, Troupin B, Schwiers ML, Day WW. Effects of low-Dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): A randomised, placebo-controlled, phase 3 trial [published correction appears in Lancet. 2011;377:1494]. Lancet. 2011;377:1341-1352
253. Garvey WT, Ryan DH, Look M, Gadde KM, Allison DB, Peterson CA, Schwiers M, Day WW, Bowden CH. Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): A randomized, placebocontrolled, phase 3 extension study. Am J Clin Nutr. 2012;95:297-308
254. Allison DB, Gadde KM, Garvey WT, Peterson CA, Schwiers ML, Najarian T, Tam PY, Troupin B, Day WW. Controlled-release phentermine/topiramate in severely obese adults: A randomized controlled trial (EQUIP). Obesity (Silver Spring). 2012;20:330-342
255. Smith SR, Weissman NJ, Anderson CM, Sanchez M, Chuang E, Stubbe S, Bays H, Shanahan WR; Behavioral Modification and Lorcaserin for Overweight and Obesity Management (BLOOM) Study Group. Multicenter, placebo-controlled trial of lorcaserin for weight management. N Engl J Med. 2010;363:245-256
256. Fidler MC, Sanchez M, Raether B, Weissman NJ, Smith SR, Shanahan WR, Anderson CM; BLOSSOM Clinical Trial Group. A one-year randomized trial of lorcaserin for weight loss in obese and overweight adults: The BLOSSOM trial. J Clin Endocrinol Metab. 2011;96:3067-3077
257. Greenway FL, Fujioka K, Plodkowski RA, Mudaliar S, Guttadauria M, Erickson J, Kim DD, Dunayevich E; COR-I Study Group. Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): A multicentre, randomised, double-blind, placebo-controlled, phase 3 trial [published corrections appear in Lancet. 2010;376:1392 and Lancet. 2010;376:594]. Lancet. 2010;376:595-605
258. Wadden TA, Foreyt JP, Foster GD, Hill JO, Klein S, O'Neil PM, Perri MG, Pi-Sunyer FX, Rock CL, Erickson JS, Maier HN, Kim DD, Dunayevich E. Weight loss with naltrexone SR/bupropion SR combination therapy as an adjunct to behavior modification: The COR-BMOD trial. Obesity (Silver Spring). 2011;19:110-120
259. Marceau P, Marceau S, Biron S, Hould FS, Lebel S, Lescelleur O, Biertho L, Kral JG. Long-term experience with duodenal switch in adolescents. Obes Surg. 2010;20:1609-1616
260. Rand CS, Macgregor AM. Adolescents having obesity surgery: A 6-year follow-up. South Med J. 1994;87:1208-1213
261. Scott WR, Batterham RL. Roux-En-Y gastric bypass and laparoscopic sleeve gastrectomy: Understanding weight loss and improvements in type 2 diabetes after bariatric surgery. Am J Physiol Regul Integr Comp Physiol. 2011;301:R15-R27
262. Chouillard EK, Karaa A, Elkhoury M, Greco VJ; Intercontinental Society of Natural Orifice, Endoscopic, and Laparoscopic Surgery (i-NOELS). Laparoscopic Roux-En-Y gastric bypass versus laparoscopic sleeve gastrectomy for morbid obesity: Case-control study. Surg Obes Relat Dis. 2011;7:500-505
263. Rosenthal RJ, Diaz AA, Arvidsson D, Baker RS, Basso N, Bellanger D, Boza C, El Mourad H, France M, Gagner M, Galvao-Neto M, Higa KD, Himpens J, Hutchinson CM, Jacobs M, Jorgensen JO, Jossart G, Lakdawala M, Nguyen NT, Nocca D, Prager G, Pomp A, Ramos AC, Rosenthal RJ, Shah S, Vix M, Wittgrove A, Zundel N; International Sleeve Gastrectomy Expert Panel. International Sleeve Gastrectomy Expert Panel Consensus Statement: Best practice guidelines based on experience of 12,000 cases. Surg Obes Relat Dis. 2012;8:8-19
264. Himpens J, Dapri G, Cadière GB. A prospective randomized study between laparoscopic gastric banding and laparoscopic isolated sleeve gastrectomy: Results after 1 and 3 years. Obes Surg. 2006;16:1450-1456
265. Karamanakos SN, Vagenas K, Kalfarentzos F, Alexandrides TK. Weight loss, appetite suppression, and changes in fasting and postprandial ghrelin and peptide-YY levels after Roux-En-Y gastric bypass and sleeve gastrectomy: A prospective, double blind study. Ann Surg. 2008;247:401-407
266. Till H, Blüher S, Hirsch W, Kiess W. Efficacy of laparoscopic sleeve gastrectomy (LSG) as a stand-alone technique for children with morbid obesity. Obes Surg. 2008;18:1047-1049
267. Till HK, Muensterer O, Keller A, Körner A, Blueher S, Merkle R, Kiess W. Laparoscopic sleeve gastrectomy achieves substantial weight loss in an adolescent girl with morbid obesity. Eur J Pediatr Surg. 2008;18:47-49
268. Velhote MC, Damiani D. Bariatric surgery in adolescents: Preliminary 1-year results with a novel technique (Santoro III). Obes Surg. 2010;20:1710-1715
269. Inge T, Helmrath M, Vierra M. The Santoro III massive enterectomy: How can we justify the risks in obese adolescents? Obes Surg. 2010;20:1718-1719